Realizing Effectiveness Across Continents With Hydroxyurea (REACH)
Realizing Effectiveness Across Continents With Hydroxyurea (REACH)
Active, not recruiting · NCT01966731 · Registry updated 2026-06-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Realizing Effectiveness Across Continents With Hydroxyurea (REACH) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, anemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, sickle cell disease | Active, not recruiting | Phase 1 / Phase 2 | 2026-06-30 | NCT01966731 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Children's Hospital Medical Center, Cincinnati | 229 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre Hospitalier Monkole | Kinshasa | Democratic Republic of the Congo | 3 |
| Hospital Pediátrico David Bernardino | Luanda | Angola | 2 |
| KEMRI/Wellcome Trust Research | Kilifi | Kenya | 2 |
| Ministry of Health Mbale Regional Hospital | Mbale | Uganda | 1 |